Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

NCT03682172 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Effect of Glucagon-like Peptide 2 on Gallbladder Motility

Interventions

DRUG: GLP-2 (1pmol/kg/min)
DRUG: GLP-2 (10pmol/kg/min)
DRUG: Placebo

Sponsor

Steno Diabetes Center Copenhagen